138
Views
25
CrossRef citations to date
0
Altmetric
PHARMACEUTICAL ANALYSIS

Electrochemical Oxidation of Pentoxifylline and its Analysis in Pure and Pharmaceutical Formulations at a Glassy Carbon Electrode

&
Pages 977-991 | Received 04 Dec 2007, Accepted 10 Jan 2008, Published online: 05 Jun 2008
 

Abstract

The oxidative behavior of pentoxifylline was studied at a glassy carbon electrode in phosphate buffer solutions using cyclic and differential-pulse voltammetry. The oxidation process was shown to be irreversible over the pH range (3.0–9.0) and was diffusion controlled. The possible mechanism of the oxidation of pentoxifylline was investigated by means of cyclic voltammetry and UV-Vis spectroscopy. An analytical method was developed for the determination of pentoxifylline in phosphate buffer solution at pH 3.0 as a supporting electrolyte. The anodic peak current varied linearly with pentoxifylline concentration in the range 2.0 × 10−8 M to 6.0 × 10−7 M of pentoxifylline with a limit of detection (LOD) of 4.42 × 10−10 M. The proposed method was applied to the determination of pentoxifylline in pure and pharmaceutical formulations.

This work is supported by the University Grant Commission, New Delhi, (No. F.30-66/2004 (SR) dated 10-11-2004) and the Special Assistance Programme (Phase II) (No. F-540/13/DRS/SAP-I Dated 28-01-2005).

Notes

a Names of the tablets.

b Each value is the mean of five experiments.

c Recovery value is the mean of five experiments.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.